Curi RMB Capital LLC bought a new stake in shares of Lam Research Co. (NASDAQ:LRCX - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 4,786 shares of the semiconductor company's stock, valued at approximately $346,000.
A number of other institutional investors and hedge funds have also recently modified their holdings of LRCX. Financial Perspectives Inc lifted its holdings in shares of Lam Research by 908.8% in the 4th quarter. Financial Perspectives Inc now owns 343 shares of the semiconductor company's stock valued at $25,000 after acquiring an additional 309 shares during the last quarter. Fairway Wealth LLC lifted its position in Lam Research by 900.0% in the fourth quarter. Fairway Wealth LLC now owns 340 shares of the semiconductor company's stock worth $25,000 after buying an additional 306 shares during the last quarter. Atwood & Palmer Inc. bought a new position in Lam Research during the fourth quarter valued at $27,000. Midwest Capital Advisors LLC purchased a new stake in shares of Lam Research in the fourth quarter valued at $27,000. Finally, Bell Investment Advisors Inc grew its holdings in Lam Research by 836.6% during the 4th quarter. Bell Investment Advisors Inc now owns 384 shares of the semiconductor company's stock valued at $28,000 after purchasing an additional 343 shares during the last quarter. 84.61% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of research analysts have recently commented on the company. Oppenheimer cut their target price on Lam Research from $95.00 to $80.00 and set an "outperform" rating on the stock in a research note on Friday, April 11th. Barclays decreased their price objective on shares of Lam Research from $75.00 to $70.00 and set an "equal weight" rating for the company in a report on Tuesday. The Goldman Sachs Group cut their price target on Lam Research from $96.00 to $85.00 and set a "buy" rating on the stock in a research note on Friday, January 10th. Needham & Company LLC reduced their price objective on shares of Lam Research from $96.00 to $80.00 and set a "buy" rating for the company in a research note on Thursday. Finally, Wolfe Research lowered shares of Lam Research from an "outperform" rating to a "peer perform" rating in a research report on Wednesday, January 15th. Six investment analysts have rated the stock with a hold rating and nineteen have given a buy rating to the company. Based on data from MarketBeat, Lam Research currently has an average rating of "Moderate Buy" and an average target price of $92.70.
Check Out Our Latest Stock Report on LRCX
Insiders Place Their Bets
In other news, SVP Seshasayee Varadarajan sold 110,080 shares of Lam Research stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $90.00, for a total value of $9,907,200.00. Following the sale, the senior vice president now owns 179,084 shares in the company, valued at $16,117,560. This trade represents a 38.07 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 0.29% of the company's stock.
Lam Research Stock Performance
Shares of NASDAQ LRCX traded up $0.52 during trading on Friday, reaching $71.42. 9,749,642 shares of the company traded hands, compared to its average volume of 12,138,062. The stock has a market cap of $91.68 billion, a P/E ratio of 21.70, a PEG ratio of 1.47 and a beta of 1.52. The firm's fifty day simple moving average is $73.15 and its 200 day simple moving average is $75.48. The company has a current ratio of 2.54, a quick ratio of 1.73 and a debt-to-equity ratio of 0.51. Lam Research Co. has a 12-month low of $56.32 and a 12-month high of $113.00.
Lam Research (NASDAQ:LRCX - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The semiconductor company reported $1.04 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.00 by $0.04. The company had revenue of $4.72 billion during the quarter, compared to the consensus estimate of $4.64 billion. Lam Research had a return on equity of 51.86% and a net margin of 26.49%. As a group, research analysts anticipate that Lam Research Co. will post 3.71 earnings per share for the current fiscal year.
Lam Research Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Wednesday, April 9th. Investors of record on Wednesday, March 5th were given a dividend of $0.23 per share. The ex-dividend date of this dividend was Wednesday, March 5th. This represents a $0.92 annualized dividend and a yield of 1.29%. Lam Research's dividend payout ratio is presently 25.63%.
Lam Research Company Profile
(
Free Report)
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Read More

Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.